📰 Nasdaq Fdmt News
Page 6 - Nasdaq Fdmt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Fdmt. Real-time updates on events, politics, business and more.
April 17, 2023
4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) had its target price lowered by SVB Securities from $14.00 to $13.00 in a report released on Thursday morning, The Fly reports. Several other equities analysts also recently weighed in on FDMT. SVB Leerink reduced their price target on 4D Molecular Therapeutics from $15.00 to $14.00 and set […]
April 17, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) – Analysts at SVB Leerink raised their FY2024 earnings per share estimates for shares of 4D Molecular Therapeutics in a report issued on Thursday, April 13th. SVB Leerink analyst M. Foroohar now expects that the company will post earnings of ($2.48) per share for the year, up […]
April 17, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective […]
April 13, 2023
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) gapped down before the market opened on Thursday after SVB Securities lowered their price target on the stock from $14.00 to $13.00. The stock had previously closed at $15.16, but opened at $14.66. 4D Molecular Therapeutics shares last traded at $15.83, with a volume of […]
April 2, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,610,000 shares, an increase of 23.7% from the February 28th total of 2,110,000 shares. Based on an average trading volume of 343,900 shares, the short-interest ratio […]
April 1, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating)’s share price dropped 4.3% during mid-day trading on Thursday . The company traded as low as $17.02 and last traded at $17.03. Approximately 68,825 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 341,463 shares. The stock had previously closed […]
March 30, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) shares dropped 4.3% during trading on Thursday . The stock traded as low as $17.02 and last traded at $17.03. Approximately 68,825 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 341,463 shares. The stock had previously closed at $17.80. […]
January 25, 2023
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Rating) – Equities research analysts at SVB Leerink issued their Q1 2023 EPS estimates for 4D Molecular Therapeutics in a report issued on Monday, January 23rd. SVB Leerink analyst M. Foroohar forecasts that the company will post earnings of ($0.75) per share for the quarter. SVB Leerink has […]
December 14, 2022
Investing in small-cap stocks is usually a very risky business, but they could offer quick and hefty returns. Also, the cheap share price of small-cap
November 16, 2022
4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) had its target price raised by Bank of America from $15.00 to $25.00 in a research note issued on Monday, The Fly reports. Bank of America‘s target price would suggest a potential upside of 33.76% from the company’s current price. FDMT has been the subject of a number […]